ROIV
Roivant Sciences Ltd.
Stock
$35.72+0.22 (+0.62%)Close Oct 2, 2026
- Revenue, FY2025
- $8.3M
- YoY, FY2025
- −71.6%
- 5-year CAGR
- −19.1%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| FY2025 | $8.3M | −71.6% |
| FY2024 | $29M | −11.2% |
| FY2023 | $33M | +3.8% |
| FY2022 | $32M | −43.0% |
| FY2021 | $55M | +132.3% |
| FY2020 | $24M | — |